A Diffuse Infiltrative CD8 Lymphocytosis Syndrome in Human Immunodeficiency Virus (HIV) Infection: A Host Immune Response Associated with HLA-DR5
- Silviu Itescu, MD;
- Lenore J. Brancato, MD;
- Joel Buxbaum, MD;
- Peter K. Gregersen, MD;
- Ciril C. Rizk, MD;
- T. Scott Croxson, MD;
- Gary E. Solomon, MD; and
- Robert Winchester, MD
Abstract
Study Objective: To describe the clinical, immunologic, and immunogenetic features of a diffuse infiltrative lymphocytic disorder resembling Sjögren syndrome in persons infected with human immunodeficiency virus (HIV).
Design: Clinical case study.
Setting: University-affiliated hospitals and outpatient clinics.
Patients: Consecutive sample of 17 patients.
Measurements and Main Results: All of the 17 patients had bilateral parotid gland enlargement; 14 had xerostomia and 6 had xerophthalmia. Of the 17 patients, 14 had generalized lymphadenopathy, 10 had histologically proved lymphocytic interstitial pneumonitis, 4 had neurologic involvement, and 3 had lymphocytic infiltration of the gastrointestinal tract. Gallium scanning in all of 11 tested patients showed abnormal salivary gland uptake. Minor salivary gland biopsies showed more than 2 lymphocytic foci per 4 mm2 tissue in all of 11 tested patients, the infiltrate consisting predominantly of CD8 cells. Fifteen patients had circulating CD 8 lymphocytosis; the principal phenotype of these cells was CD8 + CD29 +. Rheumatoid factor and antinuclear antibodies were infrequent, and none of the patients had anti-Ro/SS-A or anti-La/SS-B antibodies. HLA-DR5 was significantly more frequent in the black patients (10 of 12) compared with controls (13 of 45). Only one patient developed an opportunistic infection during 544 patient-months of study, and none has died of AIDS.
Conclusions: A distinct syndrome primarily characterized by parotid gland enlargement, sicca symptoms, and pulmonary involvement occurs in HIV infection. This disorder is associated with CD 8 lymphocytosis and the presence of HLA-DR5, and appears to be a genetically determined host immune response to HIV.
Article and Author Information
-
From New York University Medical Center, New York Veterans Affairs Medical Center, and Beth Israel Medical Center, New York, New York. For current author addresses, see end of text.
-
Grant Support: Supported in part by NIH grants AR-35626 and AI19411.
-
Requests for Reprints: Silviu Itescu, MD, Institute of Molecular Immunology, Hospital for Joint Diseases, 301 East 17th Street, New York, NY 10003.
-
Current Author Addresses: Drs. Itescu, Brancato, Solomon and Winchester: Hospital for Joint Diseases, 301 East 17th Street, New York, NY 10003.
Dr. Buxbaum: New York Veterans Affairs Medical Center, 408 First Avenue, New York, NY 10010.
Dr. Gregersen: North Shore University Hospital, 300 Community Drive, Manhasset, NY 11030.
Dr. Rizk: New York University Medical Center, 550 First Avenue, New York, NY 10016.
Dr. Croxson: Cellular Bio-Reference Laboratory, 481-B Edward Ross Drive, Elmwood Park, NJ 07407.
- © 1990 American College of Physicians
RSS Feeds









